quidel corp (QDEL:NASDAQ GS)
Timothy T. Stenzel M.D., Ph.D.
Chief Scientific Officer, Quidel Corp.
|Age||Total Calculated Compensation||This person is connected to 28 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2012
Dr. Timothy T. Stenzel, Tim, M.D., Ph.D., FACMG., has been the Chief Scientific Officer of Quidel Corp., since September 2009. Dr. Stenzel is responsible for technology assessment as well as implementing Quidel's molecular diagnostics strategy. He served as Chief Medical Officer and Vice President of Diagnostics Research and Development at Asuragen, Inc. Dr. Stenzel joined Asuragen, Inc. from Abbott Laboratories where he rose to Senior Director for Medical, Regulatory, ...
Corporate Headquarters*10165 McKellar Court
San Diego, California 92121
Board Members Memberships*
|Brian P. Concannon||Chief Executive Officer, President, Director and Member of Operating Committee|
|John A. Kraeutler||Chief Executive Officer and Director|
Meridian Bioscience, Inc.
|Franklin R. Witney Ph.D.||Chief Executive Officer, President and Director|
|Jeffrey L. Purvin||Chief Executive Officer and Director|
Response Biomedical Corp.
|Olivier Legrain||Chief Executive Officer, President and Director|
Ion Beam Applications, S.A.
|€192.5K||Compensation as of Fiscal Year 2012.|